Responses
Immunotherapy biomarkers
Original research
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
Compose a Response to This Article
Other responses
No responses have been published for this article.
